Astellas Venture Management

Astellas Venture Management accounts for 13 tracked companies with verified cap-table data, 13 of which disclose round sizes totalling $1.5B. The median disclosed raise is $72M, and the largest is Effector Therapeutics at $325M, ahead of Viamet Pharmaceuticals ($178M) and Casma Therapeutics ($162M).

The names that recur most often on these portfolio cap tables are Astellas Venture Management (13 companies), Novartis Venture Fund (3 companies), MPM Capital (3 companies), DCVC Bio (2 companies), Longwood Fund (2 companies), Alexandria Venture Investments (2 companies). By latest disclosed round, the market skews Series A (7), Series B (3), Series D (1), Grant (1).

• Companies tracked: 13
• Disclosed funding total: $1.5B across 13 companies
• Median disclosed raise: $72M
• Largest raise: Effector Therapeutics — $325M
• Stage mix: Series A 7 · Series B 3 · Series D 1 · Grant 1
• Most recent dated round: 2026-04-08

Best funded Astellas Venture Management companies

1. Effector Therapeutics — $325M (latest: Series A)
2. Viamet Pharmaceuticals — $178M (latest: Series D)
3. Casma Therapeutics — $162M (latest: Grant)
4. Sidewinder Therapeutics — $162M (latest: Series B)
5. Oncorus — $141M (latest: Series B)
6. Orna Therapeutics — $100M (latest: Series A)
7. Solu Therapeutics — $72M (latest: Series A)
8. DEM BioPharma — $70M (latest: Series A)
9. CODA Biotherapeutics — $63M (latest: Series A)
10. Redona Therapeutics — $61M (latest: Series Unknown)
11. Mogrify — $49M (latest: Series A)
12. Catamaran Bio — $42M (latest: Series A)
13. NeoPhore — $40M (latest: Series B)

Astellas Venture Management — related firms and companies (56)

• Effector Therapeutics
• Viamet Pharmaceuticals
• Casma Therapeutics
• Sidewinder Therapeutics
• Oncorus
• Orna Therapeutics
• Solu Therapeutics
• DEM BioPharma
• CODA Biotherapeutics
• Redona Therapeutics
• Mogrify
• Catamaran Bio
• NeoPhore
• Astellas Venture Management co-investors 2026
• Investors like Astellas Venture Management
• Companies backed by Astellas Venture Management
• Investors like Liquid 2 Ventures
• Investors like Amino Capital
• Investors like Wellington Management
• Investors like Ridge Ventures
• Investors like Meritech Capital Partners
• Investors like Canapi Ventures
• Investors like Maveron
• Investors like White Star Capital
• Investors like Service Provider Capital
• Investors like General Catalyst
• Investors like ACME Capital
• Investors like Index Ventures
• Investors like Fika Ventures
• Investors like Google Ventures
• Investors like Acre Venture Partners
• Investors like 500 Global
• Investors like CAVU Consumer Partners
• Investors like Bain Capital
• Investors like Maven Ventures
• Investors like Uncork Capital
• Investors like Ventioneers
• Investors like Venrock
• Investors like Oak HC/FT
• Investors like Lux Capital
• Investors like Casdin Capital
• Investors like Accomplice
• Investors like BoxGroup
• Investors like Great Oaks Venture Capital
• Investors like Canaan Partners
• Investors like F-Prime
• Investors like Menlo Ventures
• Investors like Alexandria Venture Investments
• Investors like Foundation Capital
• Investors like Capital One Ventures
• Investors like Founder Collective
• Investors like Salesforce Ventures
• Investors like Benchmark
• Investors like Coinbase
• Investors like Scale Venture Partners
• Investors like Zetta Venture Partners

Astellas Venture Management alternatives · All research reports